pyronaridine artesunate
Sponsors
Medicines for Malaria Venture, Shin Poong Pharmaceutical Co. Ltd., LSTM Liverpool School of Tropical Medicine, University of Sciences Techniques and Technologies of Bamako, Liverpool School of Tropical Medicine
Conditions
MalariaMalaria
COVID-19Malaria,Falciparum
Phase 3
Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients
CompletedNCT00422084
Start: 2007-01-31End: 2008-05-31Updated: 2021-11-02
Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria
CompletedNCT00440999
Start: 2007-03-31End: 2008-09-30Updated: 2021-11-02
Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients
CompletedNCT00541385
Start: 2007-10-31End: 2008-11-30Updated: 2021-11-22
Malaria as a risk factor for COVID-19 in western Kenya and Burkina Faso
Active, not recruitingPACTR202009642148520
Start: 2020-11-01Target: 142Updated: 2026-01-27
EFFICACY AND SAFETY OF PYRONARIDINE-ARTESUNATE (PYRAMAX) FOR THE TREATMENT OF FALCIPARUM MALARIA IN AFRICAN PREGNANT WOMEN
Active, not recruitingPACTR202011812241529
Start: 2020-07-01Target: 2002Updated: 2026-01-27
SAFIRE: Safety of Antimalarials in the FIRst Trimester
RecruitingPACTR202505891635396
Start: 2025-05-16Target: 1510Updated: 2026-01-27